JP2022543666A5 - - Google Patents
Info
- Publication number
- JP2022543666A5 JP2022543666A5 JP2022507725A JP2022507725A JP2022543666A5 JP 2022543666 A5 JP2022543666 A5 JP 2022543666A5 JP 2022507725 A JP2022507725 A JP 2022507725A JP 2022507725 A JP2022507725 A JP 2022507725A JP 2022543666 A5 JP2022543666 A5 JP 2022543666A5
- Authority
- JP
- Japan
- Prior art keywords
- pyran
- triazole
- hydroxymethyl
- thio
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019071416 | 2019-08-09 | ||
| EPPCT/EP2019/071416 | 2019-08-09 | ||
| PCT/EP2020/072238 WO2021028336A1 (en) | 2019-08-09 | 2020-08-07 | (hetero)aryl-methyl-thio-beta-d-galactopyranoside derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543666A JP2022543666A (ja) | 2022-10-13 |
| JP2022543666A5 true JP2022543666A5 (https=) | 2023-08-15 |
| JP7612662B2 JP7612662B2 (ja) | 2025-01-14 |
Family
ID=71948599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507725A Active JP7612662B2 (ja) | 2019-08-09 | 2020-08-07 | （ヘテロ）アリール－メチル－チオ－ベータ－ｄ－ガラクトピラノシド誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12404295B2 (https=) |
| EP (1) | EP4010076B1 (https=) |
| JP (1) | JP7612662B2 (https=) |
| KR (1) | KR102854071B1 (https=) |
| CN (1) | CN114206893A (https=) |
| CA (1) | CA3147082A1 (https=) |
| ES (1) | ES2972509T3 (https=) |
| TW (1) | TWI873165B (https=) |
| WO (1) | WO2021028336A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021028323A1 (en) | 2019-08-09 | 2021-02-18 | Idorsia Pharmaceuticals Ltd | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
| WO2022189459A2 (en) * | 2021-03-10 | 2022-09-15 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401301D0 (sv) * | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| EP2919802A4 (en) | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| CA2970062C (en) * | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| PL3456717T3 (pl) | 2015-07-06 | 2021-10-25 | Gilead Sciences, Inc. | Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej |
| MX394409B (es) * | 2016-03-04 | 2025-03-24 | Galectin Sciences Llc | Compuestos de seleno-galactosida para la prevención y el tratamiento de las enfermedades asociadas con galectina y el uso de los mismos. |
| CA3025867A1 (en) * | 2016-07-12 | 2018-01-18 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| EP3621973A4 (en) | 2017-05-12 | 2021-10-27 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF |
| KR20200015528A (ko) | 2017-05-12 | 2020-02-12 | 갈랙틴 사이언시즈, 엘엘씨 | 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도 |
| WO2019067702A1 (en) | 2017-09-27 | 2019-04-04 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| US11072626B2 (en) | 2017-10-11 | 2021-07-27 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| CA3080128A1 (en) | 2017-10-31 | 2019-05-09 | Galectin Sciences, Llc | Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| JP2022508720A (ja) | 2018-10-15 | 2022-01-19 | ガレクト バイオテック エービー | ガレクチンのガラクトシド阻害剤 |
| CN113286632A (zh) | 2018-10-15 | 2021-08-20 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂前药 |
| WO2020104335A1 (en) | 2018-11-21 | 2020-05-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| US12269819B2 (en) | 2019-04-10 | 2025-04-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| JP7674276B2 (ja) | 2019-07-03 | 2025-05-09 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| WO2021004940A1 (en) | 2019-07-05 | 2021-01-14 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
| WO2021028323A1 (en) | 2019-08-09 | 2021-02-18 | Idorsia Pharmaceuticals Ltd | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
-
2020
- 2020-08-07 CN CN202080056681.7A patent/CN114206893A/zh active Pending
- 2020-08-07 CA CA3147082A patent/CA3147082A1/en active Pending
- 2020-08-07 TW TW109126972A patent/TWI873165B/zh active
- 2020-08-07 EP EP20751158.5A patent/EP4010076B1/en active Active
- 2020-08-07 JP JP2022507725A patent/JP7612662B2/ja active Active
- 2020-08-07 ES ES20751158T patent/ES2972509T3/es active Active
- 2020-08-07 WO PCT/EP2020/072238 patent/WO2021028336A1/en not_active Ceased
- 2020-08-07 US US17/633,895 patent/US12404295B2/en active Active
- 2020-08-07 KR KR1020227007509A patent/KR102854071B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543666A5 (https=) | ||
| AU2012313254B2 (en) | Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors | |
| JP6254075B2 (ja) | カリウムチャネル遮断剤としてのアミン誘導体 | |
| JP6661749B2 (ja) | Ｒｏｒガンマモジュレータとしての新規化合物 | |
| JP2022543859A5 (https=) | ||
| JP2022534261A5 (https=) | ||
| TW201639829A (zh) | 經取代磺醯胺化合物 | |
| WO2020103817A1 (zh) | TGF-βR1抑制剂及其应用 | |
| JP2006525298A (ja) | アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用 | |
| TW200825062A (en) | Biaryl ether urea compounds | |
| JP6975515B2 (ja) | Ｔｒｐａ１モデュレーターとしてのスルホニルシクロアルキルカルボキサミド化合物 | |
| HRP20050045A2 (en) | Quinoline derivatives and their use as mycrobacetrial inhibitors | |
| JP2022544248A5 (https=) | ||
| JP2022546029A5 (https=) | ||
| TWI484959B (zh) | 抗細菌之喹啉衍生物（一） | |
| TW201920153A (zh) | 具有環狀構造的化合物 | |
| JP2006500403A (ja) | キノリルプロピルピペリジン誘導体およびその抗菌性物質としての使用 | |
| EP1954137A2 (en) | 2-keto-oxazoles as modulators of fatty acid amide hydrolase | |
| CN114206893A (zh) | (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物 | |
| TWI454461B (zh) | 作為ｎｋ３拮抗劑之異喹啉酮衍生物 | |
| CN110997653A (zh) | 芳基杂环哌啶酮甲酰肽2受体和甲酰肽1受体激动剂 | |
| JP4705590B2 (ja) | アリールオキシアルキルカルバメート型誘導体、これらの調製方法及び治療における該誘導体の使用 | |
| JP2024506182A5 (https=) | ||
| JP2007506703A5 (https=) | ||
| JP2010509216A (ja) | ヘテロシクリル置換抗高コレステロール血症化合物 |